Karyopharm Therapeutics Inc - KPTI - stock price prediction, stock price target, analyst ratings from 7 analysts

Karyopharm Therapeutics Inc has a share price target of US$ 26, revenue growth forecast of 2.1%, and profit growth estimate of -64.9% for FY25, based on top 7 analyst calls.